PALISADE CAPITAL MANAGEMENT, LP Q3 2021 Filing
Filed November 15, 2021
Portfolio Value
$4.6B
Holdings
407
Report Date
Q3 2021
Filing Type
13F-HR
All Holdings (407 positions)
| Stock | Value |
|---|---|
TBPHTHERAVANCE BIOPHARMA INC | $163K |
NEO 0.25 01/15/28NEOGENOMICS INC | $94K |
—SYNCHRONOSS TECHNOLOGIES INC | $90K |
IVCUSDINVACARE CORP | $76K |
—NEW YORK MTG TR INC | $30K |
—WEIBO CORP | $15K |
—FIREEYE INC | $14K |
PreviousPage 5 of 5